247 related articles for article (PubMed ID: 16494585)
1. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.
Scheiman JM; Yeomans ND; Talley NJ; Vakil N; Chan FK; Tulassay Z; Rainoldi JL; Szczepanski L; Ung KA; Kleczkowski D; Ahlbom H; Naesdal J; Hawkey C
Am J Gastroenterol; 2006 Apr; 101(4):701-10. PubMed ID: 16494585
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers.
Sostek MB; Fort JG; Estborn L; Vikman K
Curr Med Res Opin; 2011 Apr; 27(4):847-54. PubMed ID: 21319944
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
Yeomans N; Lanas A; Labenz J; van Zanten SV; van Rensburg C; Rácz I; Tchernev K; Karamanolis D; Roda E; Hawkey C; Nauclér E; Svedberg LE
Am J Gastroenterol; 2008 Oct; 103(10):2465-73. PubMed ID: 18637091
[TBL] [Abstract][Full Text] [Related]
4. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
[TBL] [Abstract][Full Text] [Related]
5. A fixed-dose combination ibuprofen and famotidine (Duexis).
Med Lett Drugs Ther; 2011 Oct; 53(1376):85-6. PubMed ID: 22033211
[TBL] [Abstract][Full Text] [Related]
6. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
[TBL] [Abstract][Full Text] [Related]
7. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
Tulassay Z; Stolte M; Sjölund M; Engstrand L; Butruk E; Malfertheiner P; Dite P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Nagy P
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):526-36. PubMed ID: 18467912
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis.
Wang X; Tian HJ; Yang HK; Wanyan P; Peng YJ
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):876-80. PubMed ID: 21900785
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Sugano K; Kontani T; Katsuo S; Takei Y; Sakaki N; Ashida K; Mizokami Y; Asaka M; Matsui S; Kanto T; Soen S; Takeuchi T; Hiraishi H; Hiramatsu N
J Gastroenterol; 2012 May; 47(5):540-52. PubMed ID: 22388884
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs.
Sugano K; Kinoshita Y; Miwa H; Takeuchi T;
BMC Gastroenterol; 2013 Mar; 13():54. PubMed ID: 23530709
[TBL] [Abstract][Full Text] [Related]
11. Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial.
Scheiman JM; Herlitz J; Veldhuyzen van Zanten SJ; Lanas A; Agewall S; Nauclér EC; Svedberg LE; Nagy P
J Cardiovasc Pharmacol; 2013 Mar; 61(3):250-7. PubMed ID: 23188121
[TBL] [Abstract][Full Text] [Related]
12. Esomeprazole: a proton pump inhibitor.
Vachhani R; Olds G; Velanovich V
Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):15-27. PubMed ID: 19210109
[TBL] [Abstract][Full Text] [Related]
13. Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trials.
Bello AE; Kent JD; Grahn AY; Rice P; Holt RJ
Postgrad Med; 2014 Jul; 126(4):82-91. PubMed ID: 25141246
[TBL] [Abstract][Full Text] [Related]
14. Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.
Angiolillo DJ; Datto C; Raines S; Yeomans ND
J Thromb Thrombolysis; 2014 Jul; 38(1):11-23. PubMed ID: 24368727
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients.
Sugano K; Kinoshita Y; Miwa H; Takeuchi T;
Aliment Pharmacol Ther; 2012 Jul; 36(2):115-25. PubMed ID: 22591121
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.
Reichel O; Dressel H; Wiederänders K; Issing WJ
Otolaryngol Head Neck Surg; 2008 Sep; 139(3):414-20. PubMed ID: 18722223
[TBL] [Abstract][Full Text] [Related]
17. Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.
Sugano K; Choi MG; Lin JT; Goto S; Okada Y; Kinoshita Y; Miwa H; Chiang CE; Chiba T; Hori M; Fukushima Y; Kim HS; Chang CY; Date M;
Gut; 2014 Jul; 63(7):1061-8. PubMed ID: 24326741
[TBL] [Abstract][Full Text] [Related]
18. Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study.
Tielemans MM; van Oijen MG; Mulder CJ; Vos KJ; Lems WF
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):281-7. PubMed ID: 22246328
[TBL] [Abstract][Full Text] [Related]
19. Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons.
Bello AE; Kent JD; Holt RJ
Phys Sportsmed; 2015 Jul; 43(3):193-9. PubMed ID: 26165391
[TBL] [Abstract][Full Text] [Related]
20. The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett's oesophagus.
Abu-Sneineh A; Tam W; Schoeman M; Fraser R; Ruszkiewicz AR; Smith E; Drew PA; Dent J; Holloway RH
Aliment Pharmacol Ther; 2010 Oct; 32(8):1023-30. PubMed ID: 20937048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
